角膜奖学金申请的趋势和申请人的特点:旧金山匹配分析
Brittany C Tsou1, Ugochi T Aguwa1, Lubaina T Arsiwala1
1Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Journal of academic ophthalmology (2017)
|June 30, 2023
概括
对于完成更多面试的美国住院毕业生来说,匹配角膜奖学金的可能性更高. 申请30多个项目降低了匹配几率,与其他眼科奖学金不同.
科学领域:
- 眼科医生 眼科 眼科
- 医学教育 医学教育
- 奖学金匹配趋势
背景情况:
- 角膜奖学金提供眼科手术专业培训.
- 了解奖学金匹配趋势和申请人因素对于项目主管和有抱负的奖学员至关重要.
研究的目的:
- 分析2014年至2019年期间填补的角膜奖学金职位的趋势.
- 为了确定与成功的角膜奖学金相匹配相关的申请人特征.
主要方法:
- 使用了非识别的旧金山 (SF) 匹配数据从2010-2017年申请人特征.
- 分析了公开可用的SF Match数据 (2014-2019) 关于课程数量,提供的/填补的职位和空缺职位.
- 使用后勤回归来确定影响比赛成功的因素.
主要成果:
- 角膜奖学金计划和提供的职位从2014-2019年增加.
- 从美国居住计划 (OR:6.15) 毕业并完成更多的面试显著增加了匹配几率.
- 申请30多个项目与比赛几率降低有关 (OR:0.97).
结论:
- 角膜奖学金的景观显示了程序和职位的增长.
- 美国居住培训和面试量是成功匹配角膜奖学金的关键预测因素.
- 建议角膜奖学金申请人采取战略申请方法,避免超过30岁的过度申请.
更多相关视频
12:36A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022
4.6K
11:29Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies
Published on: January 3, 2011
26.6K
相关概念视频
Wilcoxon Signed-Ranks Test for Matched Pairs
167
The Wilcoxon signed-rank test for matched pairs evaluates the null hypothesis by combining the ranks of differences with their signs. It essentially tests whether the median of the differences in a population of matched pairs is zero. Since the test incorporates more information than the sign test, it generally yields more trustable conclusions. This test also does not require the data to follow a normal distribution, but two conditions must be met for it to be applicable: (1) the data must...
167
Cancer Survival Analysis
397
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
397
Kaplan-Meier Approach
190
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
190
Comparing the Survival Analysis of Two or More Groups
227
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
227
Wilcoxon Signed-Ranks Test for Median of Single Population
172
The Wilcoxon signed-rank test for the median of a single population is a nonparametric test used to evaluate whether the median of a population differs from a specified value. Unlike parametric tests, it does not require data to follow a normal distribution, making it suitable for non-normal or small samples. The test begins by calculating the difference (d) between each observation and the hypothesized median. The absolute values of these differences are ranked in ascending order, with ties...
172
